Monsanto Co. (NYSE:MON) was upgraded by equities research analysts at JPMorgan Chase & Co. from a “neutral” rating to an “overweight” rating in a note issued to investors on Wednesday. The firm currently has a $128.00 price target on the stock. JPMorgan Chase & Co.’s price objective indicates a potential upside of 22.84% from the company’s current price.
MON has been the topic of several other research reports. Sanford C. Bernstein reaffirmed a “sell” rating on shares of Monsanto in a research report on Sunday, May 29th. Jefferies Group reissued a “buy” rating on shares of Monsanto in a report on Wednesday, June 29th. Piper Jaffray Cos. set a $128.00 target price on shares of Monsanto and gave the stock a “buy” rating in a report on Thursday, September 15th. Citigroup Inc. reissued a “neutral” rating and issued a $112.00 target price (up previously from $94.00) on shares of Monsanto in a report on Friday, July 1st. Finally, Zacks Investment Research raised shares of Monsanto from a “sell” rating to a “hold” rating in a report on Wednesday, June 8th. Four research analysts have rated the stock with a sell rating, seven have issued a hold rating, fifteen have given a buy rating and one has given a strong buy rating to the company. The company currently has a consensus rating of “Hold” and a consensus target price of $113.02.
Shares of Monsanto (NYSE:MON) opened at 104.20 on Wednesday. The stock’s 50 day moving average price is $105.82 and its 200 day moving average price is $100.45. The stock has a market cap of $45.60 billion, a price-to-earnings ratio of 45.86 and a beta of 1.24. Monsanto has a 52 week low of $82.81 and a 52 week high of $114.26.
Monsanto (NYSE:MON) last issued its quarterly earnings results on Wednesday, June 29th. The company reported $2.17 EPS for the quarter, missing the consensus estimate of $2.40 by $0.23. Monsanto had a return on equity of 37.98% and a net margin of 7.76%. The company had revenue of $4.19 billion for the quarter, compared to the consensus estimate of $4.49 billion. During the same period in the previous year, the business posted $2.39 EPS. The business’s revenue for the quarter was down 8.5% on a year-over-year basis. Equities research analysts anticipate that Monsanto will post $4.46 EPS for the current fiscal year.
The business also recently announced a quarterly dividend, which will be paid on Friday, October 28th. Shareholders of record on Friday, October 7th will be paid a dividend of $0.54 per share. This represents a $2.16 dividend on an annualized basis and a dividend yield of 2.07%. The ex-dividend date of this dividend is Wednesday, October 5th. Monsanto’s dividend payout ratio (DPR) is currently 89.26%.
In other Monsanto news, CEO Michael K. Stern sold 12,797 shares of Monsanto stock in a transaction on Wednesday, July 13th. The shares were sold at an average price of $101.77, for a total transaction of $1,302,350.69. Following the completion of the sale, the chief executive officer now owns 21,583 shares of the company’s stock, valued at approximately $2,196,501.91. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, COO Brett D. Begemann sold 27,980 shares of Monsanto stock in a transaction on Thursday, July 14th. The shares were sold at an average price of $103.62, for a total transaction of $2,899,287.60. Following the sale, the chief operating officer now directly owns 102,480 shares of the company’s stock, valued at approximately $10,618,977.60. The disclosure for this sale can be found here. Company insiders own 0.88% of the company’s stock.
Several large investors have recently modified their holdings of the stock. WFG Advisors LP raised its stake in shares of Monsanto by 18.6% in the second quarter. WFG Advisors LP now owns 1,009 shares of the company’s stock worth $104,000 after buying an additional 158 shares during the period. Howard Hughes Medical Institute bought a new stake in shares of Monsanto during the first quarter worth about $110,000. Signaturefd LLC raised its stake in shares of Monsanto by 62.1% in the second quarter. Signaturefd LLC now owns 1,083 shares of the company’s stock worth $112,000 after buying an additional 415 shares during the period. Mycio Wealth Partners LLC raised its stake in shares of Monsanto by 1.1% in the second quarter. Mycio Wealth Partners LLC now owns 1,094 shares of the company’s stock worth $113,000 after buying an additional 12 shares during the period. Finally, Pinkerton Retirement Specialists LLC raised its stake in shares of Monsanto by 1,179.1% in the second quarter. Pinkerton Retirement Specialists LLC now owns 1,100 shares of the company’s stock worth $114,000 after buying an additional 1,014 shares during the period. 79.06% of the stock is owned by institutional investors.
Monsanto Company Profile
Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and precision agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.
Receive News & Ratings for Monsanto Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto Co. and related companies with MarketBeat.com's FREE daily email newsletter.